Protein structure similarity as guiding principle for combinatorial library design

被引:31
作者
Koch, MA
Breinbauer, R
Waldmann, H [1 ]
机构
[1] Univ Dortmund, Max Planck Inst Mol Physiol, Abt Chem Biol, D-44227 Dortmund, Germany
[2] Univ Dortmund, Fachbereich 3, D-44227 Dortmund, Germany
关键词
bioinformatics; chemical biology; combinatorial chemistry; drug design; inhibitors; protein structure;
D O I
10.1515/BC.2003.140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins are modularly built from a limited set of approximately 1000 structural domains. The evolutionary relationship within a domain family suggests that the knowledge about a common fold structure can be exploited for the design of small molecule libraries in the development of inhibitors and ligands. This principle has been used for the synthesis of inhibitors for kinases sharing the same fold. It can also be applied for proteins which share the same fold architecture yet belong to different functional classes. Bestatin originally known as an aminopeptidase inhibitor was employed as guiding structure for the development of leukotriene A4 hydrolase inhibitors. A combinatorial approach helped to identify inhibitors for sulfotransferases which share structural similarity with nucleotide kinases using a kinase inhibitor core structure as guiding principle.
引用
收藏
页码:1265 / 1272
页数:8
相关论文
共 56 条
[1]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[2]   Chemical genetic approaches for the elucidation of signaling pathways [J].
Alaimo, PJ ;
Shogren-Knaak, MA ;
Shokat, KM .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) :360-367
[3]  
ALEXANDROV N, 1998, C BIOINF GEN REG STR
[4]   Emergence of diverse biochemical activities in evolutionarily conserved structural scaffolds of proteins [J].
Anantharaman, V ;
Aravind, L ;
Koonin, EV .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (01) :12-20
[5]  
Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO
[6]  
2-0
[7]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO
[8]  
2-D
[9]  
Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879
[10]  
Brohm D, 2002, ANGEW CHEM INT EDIT, V41, P307, DOI 10.1002/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO